Lybrate, Inc.

Lybrate, Inc. is a digital healthcare platform that enhances the interaction between patients and healthcare professionals, enabling efficient and timely medical consultations across various specialties. Founded in 2014 in Gurugram, India, Lybrate, Inc. is a digital healthcare consulting platform that connects patients with over 150,000 healthcare professionals.

The company has undergone significant changes, including its acquisition by GHV Advanced Care Private Limited in June 2022. The deal was supported by several prominent investors including Sequoia Capital and Tiger Global Management. The company's CEO is Saurabh Arora, who is one of the co-founders along with Rahul Narang. Since its establishment, Lybrate has successfully completed four funding deals, raising a total of USD 3.

00 mn through its most recent funding round in 2022. Lybrate is a premier online healthcare consulting platform facilitating doctor-patient interactions through its digital interface. It offers comprehensive telemedicine services, allowing users to consult with more than 150,000 healthcare professionals across various specialties such as general medicine, orthopedics, gynecology, and dermatology. The platform serves both urban and rural patients, providing access to timely healthcare solutions.

By leveraging technology, Lybrate operates across multiple regions in India, including major cities like Mumbai, Delhi, Bangalore, and Chennai, as well as Tier-2 and Tier-3 towns like Lucknow and Jaipur, ensuring a broad reach for its services. In the most recent fiscal year 2023, Lybrate reported a revenue of USD 554,261. 50 and an EBITDA of USD -130,579. 60.

The company employs a transactional revenue model, primarily through online consultations and partnerships with healthcare providers. Patients are charged per consultation, which can occur via video calls or chat features, while additional service charges may apply for elective surgeries conducted in affiliated healthcare facilities. Lybrate is strategically positioned for growth, focusing on enhancing its service offerings and expanding its market reach. The recent funding received will be utilized to promote and develop its existing services and potentially introduce new products aimed at improving patient engagement and access to healthcare.

The company is also looking to expand its operations into new geographic regions within India, targeting additional Tier-2 and Tier-3 cities by the end of 2023, thereby increasing its accessibility to a larger patient base.